Vutrisiran
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 161 publications
Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 26, 2026
Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 19, 2026
Combination Therapy in ATTR Cardiomyopathy: Hypothesis-Generating, Not Yet Practice-Changing.
Journal: Journal of the American College of Cardiology
Published: August 05, 2026
Targeted Therapy for ATTR-CM Amidst a Rapidly Evolving Landscape: A Moving Goalpost?
Journal: Journal of the American College of Cardiology
Published: July 30, 2026
Fewer gastrointestinal events with vutrisiran versus placebo in patients with transthyretin amyloidosis with cardiomyopathy: analysis from the phase 3 HELIOS-B study.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 17, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 09, 2026
Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.
Journal: Journal of the American College of Cardiology
Published: June 22, 2026
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.
Journal: Journal of the American College of Cardiology
Published: June 22, 2026
Cardiac Amyloidosis in Asia: What We Know and Don't Know.
Journal: JACC. Asia
Published: June 17, 2026
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: June 15, 2026
Cardiac Amyloidosis: Pathogenesis, Diagnosis, and Treatment.
Journal: Deutsches Arzteblatt international
Published: June 10, 2026
Last Updated: 09/26/2026